Cheng, Nikki <br/><br/>
Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.  [electronic resource] 

 -  Molecular cancer research : MCR  Oct 2008 
 - 1521-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1541-7786 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-07-2203  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Line, Tumor<br/>Cell Movement--drug effects<br/>Culture Media, Conditioned<br/>Female<br/>Fibroblasts--metabolism<br/>Hepatocyte Growth Factor--metabolism<br/>MAP Kinase Signaling System--drug effects<br/>Mammary Neoplasms, Experimental--enzymology<br/>Mice<br/>Mice, Knockout<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Models, Biological<br/>Neoplasm Invasiveness<br/>Protein Serine-Threonine Kinases--metabolism<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptor, Transforming Growth Factor-beta Type II<br/>Receptors, Transforming Growth Factor beta--metabolism<br/>STAT3 Transcription Factor--metabolism<br/>Signal Transduction--drug effects<br/>Transforming Growth Factor beta--metabolism